We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+8.45%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$12.4B
AUM Growth
+$271M
(+2.2%)
Cap. Flow
-$478M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
289
New
32
Increased
64
Reduced
138
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$127M |
| 2 |
Gilead Sciences
GILD
|
+$125M |
| 3 |
PayPal
PYPL
|
+$89.3M |
| 4 |
UnitedHealth
UNH
|
+$88.1M |
| 5 |
GE Aerospace
GE
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$148M |
| 2 |
Kroger
KR
|
+$105M |
| 3 |
Costco
COST
|
+$94.8M |
| 4 |
Lam Research
LRCX
|
+$79.3M |
| 5 |
Charter Communications
CHTR
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.46% |
| 2 | Technology | 16.23% |
| 3 | Industrials | 15.74% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UNVR
201
DELISTED
Univar Solutions Inc.
UNVR
| $9.12M | 0.07% |
+417,520
| New | +$8.19M |
|
202
AZZ Inc
AZZ
$4.48B
| $8.78M | 0.07% |
+134,440
| New | +$8.59M |
|
203
Cisco
CSCO
$480B
| $8.68M | 0.07% |
273,595
-300
| -0.1% | -$9.23K |
|
204
Bruker
BRKR
$7.66B
| $8.61M | 0.07% |
380,102
-207,135
| -35% | -$4.75M |
|
|
LABL
205
DELISTED
Multi-Color Corp
LABL
| $8.47M | 0.07% |
+128,350
| New | +$8.46M |
|
206
Jack Henry & Associates
JKHY
$11.1B
| $7.9M | 0.06% |
92,384
-100
| -0.1% | -$8.77K |
|
|
ACOR
207
DELISTED
Acorda Therapeutics
ACOR
| $7.43M | 0.06% |
2,966
-2,281
| -43% | -$6.81M |
|
208
Target
TGT
$67.8B
| $7.3M | 0.06% |
106,242
+41,360
| +64% | +$2.96M |
|
209
Procter & Gamble
PG
$345B
| $6.46M | 0.05% |
71,982
-30
| -0% | -$2.61K |
|
210
Johnson & Johnson
JNJ
$613B
| $6.2M | 0.05% |
52,485
-10
| -0% | -$1.21K |
|
|
MHG
211
DELISTED
Marine Harvest ASA
MHG
| $6.16M | 0.05% |
343,545
| – | – |
|
212
JPMorgan Chase
JPM
$950B
| $6.13M | 0.05% |
92,100
-200
| -0.2% | -$13K |
|
213
Pfizer
PFE
$145B
| $5.78M | 0.05% |
179,893
| – | – |
|
214
PepsiCo
PEP
$190B
| $5.73M | 0.05% |
52,684
-60
| -0.1% | -$6.46K |
|
215
Penske Automotive Group
PAG
$14.4B
| $5.7M | 0.05% |
+118,345
| New | +$4.92M |
|
216
Archer Daniels Midland
ADM
$38.5B
| $5.67M | 0.05% |
134,460
-40
| -0% | -$1.73K |
|
217
Kimberly-Clark
KMB
$35.7B
| $5.28M | 0.04% |
41,847
-1,050
| -2% | -$136K |
|
218
Coca-Cola
KO
$372B
| $5.24M | 0.04% |
123,900
-40
| -0% | -$1.75K |
|
219
AGNC Investment
AGNC
$12.6B
| $4.63M | 0.04% |
237,170
| – | – |
|
220
McDonald's
MCD
$191B
| $4.29M | 0.03% |
37,155
| – | – |
|
221
Navigator Holdings
NVGS
$1.35B
| $4.19M | 0.03% |
583,137
-983,445
| -63% | -$8.47M |
|
222
Criteo S.A. Ordinary Shares
CRTO
$1.07B
| $4.09M | 0.03% |
116,600
-389,260
| -77% | -$15.4M |
|
223
Orion
OEC
$385M
| $4.02M | 0.03% |
214,595
| – | – |
|
224
iShares Russell 2000 Growth ETF
IWO
$15B
| $4M | 0.03% |
26,880
+8,140
| +43% | +$1.19M |
|
225
Crown Castle
CCI
$33.9B
| $3.29M | 0.03% |
34,890
-364,240
| -91% | -$35M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Westfield Capital Management held 289 positions worth $12.4B, up 2.2% from $12.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $478M in Q3 2016, closing 40 positions and reducing 138 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $148M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
Against the trend, Westfield Capital Management opened a new position in Abbott worth $126M.
- Westfield Capital Management's largest Q3 2016 buy was Abbott: 2,973,638 shares worth $126M.
- Westfield Capital Management added most to UnitedHealth in Q3 2016, an estimated $88.1M increase.
- Westfield Capital Management's biggest Q3 2016 reduction was Costco, cutting an estimated $94.8M.
- Westfield Capital Management fully exited Teva Pharmaceuticals in Q3 2016, selling an estimated $148M.
- Westfield Capital Management's ten largest holdings make up 17% of its $12.4B portfolio in Q3 2016.
- Westfield Capital Management opened 32 new positions and closed 40 in Q3 2016.
- Westfield Capital Management's portfolio value rose 2.2% quarter-over-quarter to $12.4B.
Based on Westfield Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.